PFBT
HAE icon

Parkside Financial Bank & Trust’s Haemonetics HAE Stock Holding History

Parkside Financial Bank & Trust’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$85.4K Buy
1,515
+501
+49% +$32.6K 0.01% 753
2025
Q4 		$81.3K Sell
1,014
-270
-21% -$18.1K 0.01% 773
2025
Q3 		$62.6K Sell
1,284
-177
-12% -$11K ﹤0.01% 854
2025
Q2 		$109K Buy
1,461
+152
+12% +$10.1K 0.01% 625
2025
Q1 		$83.2K Buy
1,309
+133
+11% +$9.05K 0.01% 650
2024
Q4 		$91.8K Buy
1,176
+240
+26% +$19.3K 0.01% 603
2024
Q3 		$75.2K Buy
936
+58
+7% +$4.69K 0.01% 632
2024
Q2 		$72.6K Buy
878
+23
+3% +$2.02K 0.01% 617
2024
Q1 		$73K Sell
855
-199
-19% -$15.6K 0.01% 620
2023
Q4 		$90.1K Buy
1,054
+156
+17% +$13.5K 0.02% 514
2023
Q3 		$80.4K Buy
898
+112
+14% +$10K 0.02% 477
2023
Q2 		$66.9K Buy
786
+140
+22% +$11.8K 0.02% 520
2023
Q1 		$53.5K Buy
646
+197
+44% +$15.9K 0.01% 569
2022
Q4 		$35.3K Buy
449
+185
+70% +$14.9K 0.01% 681
2022
Q3 		$20K Buy
264
+9
+4% +$646 0.01% 806
2022
Q2 		$17K Hold
255
– – 0.01% 852
2022
Q1 		$16K Buy
255
+4
+2% +$218 ﹤0.01% 888
2021
Q4 		$13K Sell
251
-27
-10% -$1.65K ﹤0.01% 938
2021
Q3 		$20K Buy
278
+11
+4% +$694 0.01% 784
2021
Q2 		$17K Buy
267
+125
+88% +$8.85K ﹤0.01% 813
2021
Q1 		$16K Buy
+142
New +$17.6K ﹤0.01% 808
2018
Q2 		– Sell
-36
Closed -$3K – 1566
2018
Q1 		$3K Buy
36
+4
+13% +$274 ﹤0.01% 936
2017
Q4 		$2K Hold
32
– – ﹤0.01% 977
2017
Q3 		$1K Hold
32
– – ﹤0.01% 1132
2017
Q2 		$1K Hold
32
– – ﹤0.01% 1141
2017
Q1 		$1K Buy
32
+3
+10% +$117 ﹤0.01% 1117
2016
Q4 		$1K Buy
+29
New +$1.09K ﹤0.01% 1109

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Parkside Financial Bank & Trust's HAE Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Haemonetics (HAE) stake by 49% in Q1 2026, buying an estimated $32.6K and bringing the position to 1,515 shares worth $85.4K. The position accounts for 0.01% of the portfolio, ranked #753.

Parkside Financial Bank & Trust first reported a position in HAE in Q4 2016 and has held it in 27 quarters since. The position peaked at $109K in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,515 shares of Haemonetics worth $85.4K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 501 Haemonetics shares in Q1 2026, an estimated $32.6K.
  • Haemonetics made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #753 holding.
  • Parkside Financial Bank & Trust first reported a position in Haemonetics in Q4 2016 and has held it in 27 quarters since.
  • Parkside Financial Bank & Trust's Haemonetics position peaked at $109K in Q2 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.